Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American society of echocardiography and the European association of cardiovascular imaging

Journal of the American Society of Echocardiography

Volumn 27, Issue 9, 2014, Pages 911-939

  Plana, Juan Carlos ^a   Galderisi, Maurizio ^b   Barac, Ana ^c   Ewer, Michael S ^d   Ky, Bonnie ^e   Scherrer Crosbie, Marielle ^f   Ganame, Javier ^g   Sebag, Igal A ^h   Agler, Deborah A ^a   Badano, Luigi P ⁱ   Banchs, Jose ^d   Cardinale, Daniela ^j   Carver, Joseph ^k   Cerqueira, Manuel ^a   Decara, Jeanne M ^l   Edvardsen, Thor ^m   Flamm, Scott D ^a   Force, Thomas ⁿ   Griffin, Brian P ^a   Jerusalem, Guy ^o   Liu, Jennifer E ^p   Magalhães, Andreia ^q   Marwick, Thomas ^r   Sanchez, Liza Y ^d   Sicari, Rosa ^s   Villarraga, Hector R ^t   Lancellotti, Patrizio ^o   more..

^a LERNER RESEARCH INSTITUTE   (United States)

^b FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g MCMASTER UNIVERSITY   (Canada)

^h MCGILL UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF PADOVA   (Italy)

^j EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

^l UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^m OSLO UNIVERSITY HOSPITAL   (Norway)

ⁿ TEMPLE UNIVERSITY   (United States)

^o UNIVERSITY OF LIÈGE   (Belgium)

^p MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^q Santa Marie University Hospital   (Portugal)

^r UNIVERSITY OF TASMANIA   (Australia)

^s INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^t MAYO CLINIC   (United States)

more..

Author keywords

Biomarkers; Chemotherapy; Doxorubicin; Early detection; Left ventricular dysfunction; Strain; Three dimensional echocardiography; Trastuzumab

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; DOXORUBICIN; TRASTUZUMAB; TROPONIN;

CANCER PATIENT; CANCER THERAPEUTICS RELATED CARDIAC DYSFUNCTION; CANCER THERAPY; CARDIAC IMAGING; CARDIOTOXICITY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL EVALUATION; CONSENSUS; CONTRAST ECHOCARDIOGRAPHY; DIASTOLIC DYSFUNCTION; DIFFUSION TENSOR IMAGING; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HUMAN; NONHUMAN; PERICARDIAL DISEASE; REVIEW; SCINTIANGIOGRAPHY; STRESS ECHOCARDIOGRAPHY; SYSTEMATIC REVIEW (TOPIC); THREE DIMENSIONAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE; ADULT; ADVERSE EFFECTS; CARDIOLOGY; CHEMORADIOTHERAPY; ETIOLOGY; EUROPE; FEMALE; MALE; MULTIMODAL IMAGING; NEOPLASMS; ONCOLOGY; PRACTICE GUIDELINE; PREVENTION AND CONTROL; RADIOLOGY; STANDARDS; UNITED STATES;

ADULT; CARDIOLOGY; CHEMORADIOTHERAPY; EUROPE; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY; MULTIMODAL IMAGING; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; RADIOLOGY; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84906834548     PISSN: 08947317     EISSN: 10976795     Source Type: Journal    
DOI: 10.1016/j.echo.2014.07.012     Document Type: Article

References (238)

1. C. Tan, H. Tasaka, K.P. Yu, M.L. Murphy, and D.A. Karnofsky Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia Cancer 20 1967 333 353
2. J. Alexander, N. Dainiak, H.J. Berger, L. Goldman, D. Johnstone, and L. Reduto et al. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography N Engl J Med 300 1979 278 283
3. R. Lenzhofer, R. Dudczak, G. Gumhold, W. Graninger, K. Moser, and K.H. Spitzy Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy J Cancer Res Clin Oncol 106 1983 136 142
4. A. Ramos, R.A. Meyer, J. Korfhagen, K.Y. Wong, and S. Kaplan Echocardiographic evaluation of adriamycin cardiotoxicity in children Cancer Treat Rep 60 1976 1281 1284
5. M.S. Ewer, M.K. Ali, B. Mackay, S. Wallace, M. Valdivieso, and S.S. Legha et al. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin J Clin Oncol 2 1984 112 117
6. T.G. Neilan, D.S. Jassal, T.M. Perez-Sanz, M.J. Raher, A.D. Pradhan, and E.S. Buys et al. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury Eur Heart J 27 2006 1868 1875
7. M.G. Khouri, P.S. Douglas, J.R. Mackey, M. Martin, J.M. Scott, and M. Scherrer-Crosbie et al. Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues Circulation 126 2012 2749 2763
8. S. Zhang, X. Liu, T. Bawa-Khalfe, L.S. Lu, Y.L. Lyu, and L.F. Liu et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity Nat Med 18 2012 1639 1642
9. M.A. Friedman, M.J. Bozdech, M.E. Billingham, and A.K. Rider Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals JAMA 240 1978 1603 1606
10. M.S. Ewer, and S.M. Lippman Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity J Clin Oncol 23 2005 2900 2902
11. G.M. Felker, R.E. Thompson, J.M. Hare, R.H. Hruban, D.E. Clemetson, and D.L. Howard et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy N Engl J Med 342 2000 1077 1084
12. H. Lal, K.L. Kolaja, and T. Force Cancer genetics and the cardiotoxicity of the therapeutics J Am Coll Cardiol 61 2013 267 274
13. M. Ewer, D. Suter, D.J. Lenihan, L. Niculescu, A. Breazna, and R.J. Motzer et al. Sunitinib-related hypertension is a randomized placebo-controlled trial of GIST patients J Clin Oncol 28 2010 abstract 10059-abstract 10059
14. ®) in HER2-positive early breast cancer The Breast 16 2007 S63
15. I.N. Daher, C. Kim, R.R. Saleh, J.C. Plana, S.W. Yusuf, and J. Banchs Prevalence of abnormal echocardiographic findings in cancer patients: a retrospective evaluation of echocardiography for identifying cardiac abnormalities in cancer patients Echocardiography 28 2011 1061 1067
16. M.D. Cheitlin, W.F. Armstrong, G.P. Aurigemma, G.A. Beller, F.Z. Bierman, and J.L. Davis et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) J Am Soc Echocardiogr 16 2003 1091 1110
17. American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, and Heart Rhythm Society et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians J Am Soc Echocardiogr 24 2011 229 267
18. R.M. Steingart, G.L. Bakris, H.X. Chen, M.H. Chen, T. Force, and S.P. Ivy et al. Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors Am Heart J 163 2012 156 163
19. T. Eschenhagen, T. Force, M.S. Ewer, G.W. de Keulenaer, T.M. Suter, and S.D. Anker et al. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail 13 2011 1 10
20. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
21. J.M. Isner, V.J. Ferrans, S.R. Cohen, B.G. Witkind, R. Virmani, and J.S. Gottdiener et al. Clinical and morphologic cardiac findings after anthracycline chemotherapy. Analysis of 64 patients studied at necropsy Am J Cardiol 51 1983 1167 1174
22. D. Muraru, L.P. Badano, D. Peluso, L. Dal Bianco, S. Casablanca, and G. Kocabay et al. Comprehensive analysis of left ventricular geometry and function by three-dimensional echocardiography in healthy adults J Am Soc Echocardiogr 26 2013 618 628
23. E.R. Rietzschel, M.L. De Buyzere, S. Bekaert, P. Segers, D. De Bacquer, and L. Cooman et al. Rationale, design, methods and baseline characteristics of the Asklepios Study Eur J Cardiovasc Prev Rehabil 14 2007 179 191
24. T. Kuznetsova, L. Herbots, B. Lopez, Y. Jin, T. Richart, and L. Thijs et al. Prevalence of left ventricular diastolic dysfunction in a general population Circ Heart Fail 2 2009 105 112
25. G.D. Friedman, G.R. Cutter, R.P. Donahue, G.H. Hughes, S.B. Hulley, and D.R. Jacobs Jr. et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects J Clin Epidemiol 41 1988 1105 1116
26. P. Lancellotti, L.P. Badano, R.M. Lang, N. Akhaladze, G.D. Athanassopoulos, and D. Barone et al. Normal Reference Ranges for Echocardiography: rationale, study design, and methodology (NORRE Study) Eur Heart J Cardiovasc Imaging 14 2013 303 308
27. M. Bountioukos, J.K. Doorduijn, J.R. Roelandt, E.C. Vourvouri, J.J. Bax, and A.F. Schinkel et al. Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity Eur J Echocardiogr 4 2003 300 305
28. M. Ryberg, D. Nielsen, T. Skovsgaard, J. Hansen, B.V. Jensen, and P. Dombernowsky Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer J Clin Oncol 16 1998 3502 3508
29. D. Nielsen, J.B. Jensen, P. Dombernowsky, O. Munck, J. Fogh, and I. Brynjolf et al. Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer J Clin Oncol 8 1990 1806 1810
30. S.M. Swain, F.S. Whaley, and M.S. Ewer Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer 97 2003 2869 2879
31. I. Mitani, D. Jain, T.M. Joska, B. Burtness, and B.L. Zaret Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era J Nucl Cardiol 10 2003 132 139
32. T. Nousiainen, E. Jantunen, E. Vanninen, and J. Hartikainen Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients Br J Cancer 86 2002 1697 1700
33. R.G. Schwartz, W.B. McKenzie, J. Alexander, P. Sager, A. D'Souza, and A. Manatunga et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography Am J Med 82 1987 1109 1118
34. B.V. Jensen, T. Skovsgaard, and S.L. Nielsen Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients Ann Oncol 13 2002 699 709
35. L.J. Steinherz, P.G. Steinherz, C.T. Tan, G. Heller, and M.L. Murphy Cardiac toxicity 4 to 20 years after completing anthracycline therapy JAMA 266 1991 1672 1677
36. L. Moja, L. Tagliabue, S. Balduzzi, E. Parmelli, V. Pistotti, and V. Guarneri et al. Trastuzumab containing regimens for early breast cancer Cochrane Database Syst Rev 4 2012 CD006243
37. A. Seidman, C. Hudis, M.K. Pierri, S. Shak, V. Paton, and M. Ashby et al. Cardiac dysfunction in the trastuzumab clinical trials experience J Clin Oncol 20 2002 1215 1221
38. G. Youssef, and M. Links The prevention and management of cardiovascular complications of chemotherapy in patients with cancer Am J Cardiovasc Drugs 5 2005 233 243
39. D.L. Keefe Trastuzumab-associated cardiotoxicity Cancer 95 2002 1592 1600
40. L.M. Schuchter, M.L. Hensley, N.J. Meropol, and E.P. Winer American Society of Clinical Oncology Chemotherapy and Radiotherapy Expert Panel. 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology J Clin Oncol 20 2002 2895 2903
41. J.R. Carver, C.L. Shapiro, A. Ng, L. Jacobs, C. Schwartz, and K.S. Virgo et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects J Clin Oncol 25 2007 3991 4008
42. L.D. Jacobs, I.S. Salgo, S. Goonewardena, L. Weinert, P. Coon, and D. Bardo et al. Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiographic data Eur Heart J 27 2006 460 468
43. J.E. Otterstad, G. Froeland, M. St John Sutton, and I. Holme Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function Eur Heart J 18 1997 507 513
44. P. Thavendiranathan, A.D. Grant, T. Negishi, J.C. Plana, Z.B. Popovic, and T.H. Marwick Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy J Am Coll Cardiol 61 2013 77 84
45. M.S. Ewer, and S.M. Ewer Long-term cardiac safety of dose-dense anthracycline therapy cannot be predicted from early ejection fraction data J Clin Oncol 27 2009 6073 6075
46. C. Karakurt, G. Kocak, and U. Ozgen Evaluation of the left ventricular function with tissue tracking and tissue Doppler echocardiography in pediatric malignancy survivors after anthracycline therapy Echocardiography 25 2008 880 887
47. J. Ganame, P. Claus, B. Eyskens, A. Uyttebroeck, M. Renard, and J. D'hooge et al. Acute cardiac functional and morphological changes after Anthracycline infusions in children Am J Cardiol 99 2007 974 977
48. S. Tassan-Mangina, D. Codorean, M. Metivier, B. Costa, C. Himberlin, and C. Jouannaud et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study Eur J Echocardiogr 7 2006 141 146
49. L. Kapusta, J.M. Thijssen, J. Groot-Loonen, T. Antonius, J. Mulder, and O. Daniels Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines Ultrasound Med Biol 26 2000 1099 1108
50. S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, and O.A. Smiseth et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography Eur J Echocardiogr 10 2009 165 193
51. J.W. Mason, M.R. Bristow, M.E. Billingham, and J.R. Daniels Invasive and non invasive methods of assessing Adriamycin cardiotoxic effects in man: superiority of histiopathologic assessment using endomyocardial biopsy Cancer Treat Rep 62 1978 857 864
52. A. Tanindi, U. Demirci, G. Tacoy, S. Buyukberber, Y. Alsancak, and U. Coskun et al. Assessment of right ventricular functions during cancer chemotherapy Eur J Echocardiogr 12 2011 834 840
53. L.G. Rudski, W.W. Lai, J. Afilalo, L. Hua, M.D. Handschumacher, and K. Chandrasekaran et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography J Am Soc Echocardiogr 23 2010 685 713 quiz 786-8
54. D. Montani, E. Bergot, S. Gunther, L. Savale, A. Bergeron, and A. Bourdin et al. Pulmonary arterial hypertension in patients treated by dasatinib Circulation 125 2012 2128 2137
55. R.C. Bansal Infective endocarditis Med Clin North Am 79 1995 1205 1240
56. W.C. Roberts The congenitally bicuspid aortic valve. A study of 85 autopsy cases Am J Cardiol 26 1970 72 83
57. L.A. Freed, D. Levy, R.A. Levine, M.G. Larson, J.C. Evans, and D.L. Fuller et al. Prevalence and clinical outcome of mitral-valve prolapse N Engl J Med 341 1999 1 7
58. P. Lancellotti, V.T. Nkomo, L.P. Badano, J. Bergler, J. Bogaert, and L. Davin et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography Eur Heart J Cardiovasc Imaging 14 2013 721 740
59. Y. Edoute, N. Haim, D. Rinkevich, B. Brenner, and S.A. Reisner Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study of 200 patients Am J Med 102 1997 252 258
60. P.W. Eiken, W.D. Edwards, H.D. Tazelaar, R.D. McBane, and K.J. Zehr Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000 Mayo Clin Proc 76 2001 1204 1212
61. A. Hamza, P.A. Tunick, and I. Kronzon Echocardiographic manifestations of complications of radiation therapy Echocardiography 26 2009 724 728
62. P.A. Heidenreich, and J.R. Kapoor Radiation induced heart disease: systemic disorders in heart disease Heart 95 2009 252 258
63. P.A. Heidenreich, S.L. Hancock, B.K. Lee, C.S. Mariscal, and I. Schnittger Asymptomatic cardiac disease following mediastinal irradiation J Am Coll Cardiol 42 2003 743 749
64. D. Tomlinson, L.A. Mermel, M.C. Ethier, A. Matlow, B. Gillmeister, and L. Sung Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review Clin Infect Dis 53 2011 697 710
65. H. Baumgartner, J. Hung, J. Bermejo, J.B. Chambers, A. Evangelista, and B.P. Griffin et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice J Am Soc Echocardiogr 22 2009 1 23 quiz 101-2
66. P. Lancellotti, C. Tribouilloy, A. Hagendorff, B.A. Popescu, T. Edvardsen, and L.A. Pierard et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging Eur Heart J Cardiovasc Imaging 14 2013 611 644
67. B. Cosyns, M. Garbi, J. Separovic, A. Pasquet, and P. Lancellotti Education Committee of the European Association of Cardiovascular Imaging Association (EACVI). Update of the Echocardiography Core Syllabus of the European Association of Cardiovascular Imaging (EACVI) Eur Heart J Cardiovasc Imaging 14 2013 837 839
68. W.A. Zoghbi, M. Enriquez-Sarano, E. Foster, P.A. Grayburn, C.D. Kraft, and R.A. Levine et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography J Am Soc Echocardiogr 16 2003 777 802
69. A. Mugge, W.G. Daniel, G. Frank, and P.R. Lichtlen Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach J Am Coll Cardiol 14 1989 631 638
70. A.L. Klein, S. Abbara, D.A. Agler, C.P. Appleton, C.R. Asher, and B. Hoit et al. American society of echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the society for cardiovascular magnetic resonance and society of cardiovascular computed tomography J Am Soc Echocardiogr 26 2013 965 1012 e15
71. R.O. Bonow, B.A. Carabello, K. Chatterjee, A.C. de Leon Jr., D.P. Faxon, and M.D. Freed et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 52 2008 e1 e142
72. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) European Association for Cardio-Thoracic Surgery (EACTS) A. Vahanian, O. Alfieri, F. Andreotti, and M.J. Antunes et al. Guidelines on the management of valvular heart disease (version 2012) Eur Heart J 33 2012 2451 2496
73. D.L. Morton, D.L. Glancy, W.L. Joseph, and P.C. Adkins Management of patients with radiation-induced pericarditis with effusion: a note on the development of aortic regurgitation in two of them Chest 64 1973 291 297
74. A.M. Gaya, and R.F. Ashford Cardiac complications of radiation therapy Clin Oncol (R Coll Radiol) 17 2005 153 159
75. J. Krupicka, J. Markova, D. Pohlreich, T. Kozak, H. Linkova, and V. Diehl et al. Echocardiographic evaluation of acute cardiotoxicity in the treatment of Hodgkin disease according to the German Hodgkin's Lymphoma Study Group Leuk Lymphoma 43 2002 2325 2329
76. S. Tohda, H. Kobayashi, T. Suzuki, T. Koyama, T. Kamiyama, and Y. Nakamura et al. Acute pericarditis caused by daunorubicin in acute myelocytic leukemia Rinsho Ketsueki 29 1988 874 878
77. D.J. Casey, A.Y. Kim, and A.J. Olszewski Progressive pericardial effusion during chemotherapy for advanced Hodgkin lymphoma Am J Hematol 87 2012 521 524
78. H. Dazzi, K. Kaufmann, and F. Follath Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia. Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity in patients treated for acute leukaemia at the University Hospital of Zurich, Switzerland, between 1990 and 1996 Ann Oncol 12 2001 963 966
79. M. Katayama, Y. Imai, H. Hashimoto, M. Kurata, K. Nagai, and K. Tamita et al. Fulminant fatal cardiotoxicity following cyclophosphamide therapy J Cardiol 54 2009 330 334
80. G.W. Santos, L.L. Sensenbrenner, P.J. Burke, M. Colvin, A.H. Owens Jr., and W.B. Bias et al. Marrow transplanation in man following cyclophosphamide Transplant Proc 3 1971 400 404
81. J.S. Gottdiener, F.R. Appelbaum, V.J. Ferrans, A. Deisseroth, and J. Ziegler Cardiotoxicity associated with high-dose cyclophosphamide therapy Arch Intern Med 141 1981 758 763
82. M.A. Goldberg, J.H. Antin, E.C. Guinan, and J.M. Rappeport Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor Blood 68 1986 1114 1118
83. R. Yamamoto, Y. Kanda, T. Matsuyama, K. Oshima, Y. Nannya, and M. Suguro et al. Myopericarditis caused by cyclophosphamide used to mobilize peripheral blood stem cells in a myeloma patient with renal failure Bone Marrow Transplant 26 2000 685 688
84. A.C. Braverman, J.H. Antin, M.T. Plappert, E.F. Cook, and R.T. Lee Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens J Clin Oncol 9 1991 1215 1223
85. A. Gahler, F. Hitz, U. Hess, and T. Cerny Acute pericarditis and pleural effusion complicating cytarabine chemotherapy Onkologie 26 2003 348 350
86. S. Reykdal, R. Sham, and P. Kouides Cytarabine-induced pericarditis: a case report and review of the literature of the cardio-pulmonary complications of cytarabine therapy Leuk Res 19 1995 141 144
87. T. Yamada, H. Tsurumi, T. Hara, M. Sawada, M. Oyama, and H. Moriwaki Cytarabine-induced pericarditis Rinsho Ketsueki 39 1998 1115 1120
88. C. Hermans, N. Straetmans, J.L. Michaux, and A. Ferrant Pericarditis induced by high-dose cytosine arabinoside chemotherapy Ann Hematol 75 1997 55 57
89. L. Vaickus, and L. Letendre Pericarditis induced by high-dose cytarabine therapy Arch Intern Med 144 1984 1868 1869
90. J.C. Barton, S.C. Jones, W.C. Lamberth, M.T. Reymann, and V.C. Scott Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia Am J Hematol 71 2002 139 140
91. M. Breccia, G.M. D'Elia, M. D'Andrea, R. Latagliata, and G. Alimena Pleural-pericardic effusion as uncommon complication in CML patients treated with Imatinib Eur J Haematol 74 2005 89 90
92. M. Breccia, and G. Alimena Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development Expert Opin Drug Saf 9 2010 713 721
93. M.T. Krauth, S. Herndlhofer, M.T. Schmook, G. Mitterbauer-Hohendanner, E. Schlogl, and P. Valent Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily Haematologica 96 2011 163 166
94. J. Rauw, S. Ahmed, and T. Petrella Pericardial effusion and tamponade following interferon alpha treatment for locally advanced melanoma Med Oncol 29 2012 1304 1307
95. J.I. Cervera Miguel, M. Vallalta, E. Iranzo, and V. Navarro Ibanez Pericardial effusion associated with interferon therapy Med Clin (Barc) 122 2004 636 637
96. J. Velasco, I. Orinuela, A.Z. Sanjuan, and Z. Ortiz de Zarate Pericardial effusion associated to interferon in an immunocompetent patient Enferm Infecc Microbiol Clin 28 2010 749 750
97. B. Wisniewski, J. Denis, D. Fischer, and D. Labayle Pericarditis secondary to interferon alpha in chronic hepatitis C Gastroenterol Clin Biol 28 2004 315 316
98. C. Popescu, V. Arama, and S. Gliga Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report BMC Gastroenterol 11 2011 30 230 X-11-30
99. M.S. Tallman, J.W. Andersen, C.A. Schiffer, F.R. Appelbaum, J.H. Feusner, and A. Ogden et al. All-trans-retinoic acid in acute promyelocytic leukemia N Engl J Med 337 1997 1021 1028
100. S.R. Frankel, A. Eardley, G. Lauwers, M. Weiss, and R.P. Warrell Jr. The "retinoic acid syndrome" in acute promyelocytic leukemia Ann Intern Med 117 1992 292 296
101. W. Terpstra, and C.E. de Maat Pericardial fibrosis following busulfan treatment Neth J Med 35 1989 249 252
102. L.N. Forbat, B.W. Hancock, and A.H. Gershlick Methotrexate-induced pericarditis and pericardial effusion; first reported case Postgrad Med J 71 1995 244 245
103. F. Savoia, G. Gaddoni, C. Casadio, A. Patrizi, G. Spadola, and P. Bassi et al. A case of aseptic pleuropericarditis in a patient with chronic plaque psoriasis under methotrexate therapy Dermatol Online J 16 2010 13
104. T. Mohyuddin, M. Elyan, and I. Kushner Pericarditis: a rare complication of methotrexate therapy Clin Rheumatol 26 2007 2157 2158
105. P. Palungwachira, P. Palungwachira, and P. Laohathai Methotrexate induced pericarditis and pericardial effusion in psoriatic patient J Med Assoc Thai 81 1998 141 145
106. S.Y. Huang, C.S. Chang, J.L. Tang, H.F. Tien, T.L. Kuo, and S.F. Huang et al. Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia Br J Haematol 103 1998 1092 1095
107. K. Ueda, S. Nagai, S.I. Miyashita, T. Kaise, M. Ichikawa, and K. Kumano et al. Arsenic-induced pericardial and pleural effusion without acute promyelocytic leukemia differentiation syndrome Leuk Res 34 2010 e25 e26
108. A.N. Calik, E. Celiker, Y. Velibey, M. Cagdas, and O. Guzelburc Initial dose effect of 5-fluorouracil: rapidly improving severe, acute toxic myopericarditis Am J Emerg Med 30 2012 257.e1 257.e3
109. B. Vincenzi, D. Santini, A.M. Frezza, L. Rocci, and G. Tonini Docetaxel induced pericardial effusion J Exp Clin Cancer Res 26 2007 417 420
110. B. Maisch, P.M. Seferovic, A.D. Ristic, R. Erbel, R. Rienmuller, and Y. Adler et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology Eur Heart J 25 2004 587 610
111. C.P. Appleton, L.K. Hatle, and R.L. Popp Cardiac tamponade and pericardial effusion: respiratory variation in transvalvular flow velocities studied by Doppler echocardiography J Am Coll Cardiol 11 1988 1020 1030
112. M. Pepi, and M. Muratori Echocardiography in the diagnosis and management of pericardial disease J Cardiovasc Med 7 2006 533 544
113. S. Wann, and E. Passen Echocardiography in pericardial disease J Am Soc Echocardiogr 21 2008 7 13
114. M.M. Applefeld, J.F. Cole, S.H. Pollock, F.J. Sutton, R.G. Slawson, and R.T. Singleton et al. The late appearance of chronic pericardial disease in patients treated by radiotherapy for Hodgkin's disease Ann Intern Med 94 1981 338 341
115. G.C. Kane, R.N. Edie, and J.D. Mannion Delayed appearance of effusive-constrictive pericarditis after radiation for Hodgkin lymphoma Ann Intern Med 124 1996 534 535
116. J.E. Tulleken, C.G. Kooiman, T.S. van der Werf, J.G. Zijlstra, and E.G. de Vries Constrictive pericarditis after high-dose chemotherapy Lancet 350 1997 1601
117. T. Oki, T. Tabata, H. Yamada, M. Abe, Y. Onose, and T. Wakatsuki et al. Right and left ventricular wall motion velocities as diagnostic indicators of constrictive pericarditis Am J Cardiol 81 1998 465 470
118. P.P. Sengupta, J.C. Mohan, V. Mehta, R. Arora, N.G. Pandian, and B.K. Khandheria Accuracy and pitfalls of early diastolic motion of the mitral annulus for diagnosing constrictive pericarditis by tissue Doppler imaging Am J Cardiol 93 2004 886 890
119. D.W. Sohn, Y.J. Kim, H.S. Kim, K.B. Kim, Y.B. Park, and Y.S. Choi Unique features of early diastolic mitral annulus velocity in constrictive pericarditis J Am Soc Echocardiogr 17 2004 222 226
120. L.P. Badano, F. Boccalini, D. Muraru, L.D. Bianco, D. Peluso, and R. Bellu et al. Current clinical applications of transthoracic three-dimensional echocardiography J Cardiovasc Ultrasound 20 2012 1 22
121. G.T. Armstrong, J.C. Plana, N. Zhang, D. Srivastava, D.M. Green, and K.K. Ness et al. Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging J Clin Oncol 30 2012 2876 2884
122. C. Jenkins, S. Moir, J. Chan, D. Rakhit, B. Haluska, and T.H. Marwick Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging Eur Heart J 30 2009 98 106
123. D.L. King, M.R. Harrison, D.L. King Jr., A.S. Gopal, O.L. Kwan, and A.N. DeMaria Ultrasound beam orientation during standard two-dimensional imaging: assessment by three-dimensional echocardiography J Am Soc Echocardiogr 5 1992 569 576
124. M. Cannesson, M. Tanabe, M.S. Suffoletto, D.M. McNamara, S. Madan, and J.M. Lacomis et al. A novel two-dimensional echocardiographic image analysis system using artificial intelligence-learned pattern recognition for rapid automated ejection fraction J Am Coll Cardiol 49 2007 217 226
125. D. Muraru, L.P. Badano, G. Piccoli, P. Gianfagna, L. Del Mestre, and D. Ermacora et al. Validation of a novel automated border-detection algorithm for rapid and accurate quantitation of left ventricular volumes based on three-dimensional echocardiography Eur J Echocardiogr 11 2010 359 368
126. V. Mor-Avi, and R.M. Lang Is echocardiography reliable for monitoring the adverse cardiac effects of chemotherapy? J Am Coll Cardiol 61 2013 85 87
127. W. Tsang, C. Kenny, S. Adhya, S. Kapetanakis, L. Weinert, and R.M. Lang et al. Interinstitutional measurements of left ventricular volumes, speckle-tracking strain, and dyssynchrony using three-dimensional echocardiography J Am Soc Echocardiogr 26 2013 1253 1257
128. E.H. Yu, C.E. Sloggett, R.M. Iwanochko, H. Rakowski, and S.C. Siu Feasibility and accuracy of left ventricular volumes and ejection fraction determination by fundamental, tissue harmonic, and intravenous contrast imaging in difficult-to-image patients J Am Soc Echocardiogr 13 2000 216 224
129. S.L. Mulvagh, H. Rakowski, M.A. Vannan, S.S. Abdelmoneim, H. Becher, and S.M. Bierig et al. American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography J Am Soc Echocardiogr 21 2008 1179 1201 quiz 1281
130. R. Senior, H. Becher, M. Monaghan, L. Agati, J. Zamorano, and J.L. Vanoverschelde et al. Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography Eur J Echocardiogr 10 2009 194 212
131. P.S. Douglas, J.J. Carr, M.D. Cerqueira, J.E. Cummings, T.C. Gerber, and D. Mukherjee et al. Developing an action plan for patient radiation safety in adult cardiovascular medicine: proceedings from the Duke University Clinical Research Institute/American College of Cardiology Foundation/American Heart Association Think Tank held on February 28, 2011 J Am Coll Cardiol 59 2012 1833 1847
132. E.T.H. Yeh, and C.L. Bickford Cardiovascular Complications of Cancer Therapy: Incidence, Pathogenesis, Diagnosis, and Management J Am Coll Cardiol 53 2009 2231 2247
133. M. Jarfelt, V. Kujacic, D. Holmgren, R. Bjarnason, and B. Lannering Exercise echocardiography reveals subclinical cardiac dysfunction in young adult survivors of childhood acute lymphoblastic leukemia Pediatr Blood Cancer 49 2007 835 840
134. D. De Wolf, B. Suys, R. Maurus, Y. Benoit, H. Verhaaren, and D. Matthijs et al. Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors Pediatr Res 39 1996 504 512
135. D. De Wolf, B. Suys, H. Verhaaren, D. Matthys, and Y. Taeymans Low-dose dobutamine stress echocardiography in children and young adults Am J Cardiol 81 1998 895 901
136. Y. Cottin, I. L'huillier, O. Casasnovas, C. Geoffroy, D. Caillot, and M. Zeller et al. Dobutamine stress echocardiography identifies anthracycline cardiotoxicity Eur J Echocardiogr 1 2000 180 183
137. L. Lanzarini, G. Bossi, M.L. Laudisa, C. Klersy, and M. Arico Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines Am Heart J 140 2000 315 323
138. L. Elbl, H. Hrstkova, V. Chaloupka, J. Novotny, and J. Michalek The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography Neoplasma 50 2003 191 197
139. H. Hamada, T. Ohkubo, M. Maeda, and S. Ogawa Evaluation of cardiac reserved function by high-dose dobutamine-stress echocardiography in asymptomatic anthracycline-treated survivors of childhood cancer Pediatr Int 48 2006 313 320
140. M. Civelli, D. Cardinale, A. Martinoni, G. Lamantia, N. Colombo, and A. Colombo et al. Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity Int J Cardiol 111 2006 120 126
141. A. Grosu, T. Bombardini, M. Senni, V. Duino, M. Gori, and E. Picano End-systolic pressure/volume relationship during dobutamine stress echo: a prognostically useful non-invasive index of left ventricular contractility Eur Heart J 26 2005 2404 2412
142. E. Tan-Chiu, G. Yothers, E. Romond, C.E. Geyer Jr., M. Ewer, and D. Keefe et al. Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31 J Clin Oncol 23 2005 7811 7819
143. D. Cardinale, A. Colombo, G. Lamantia, N. Colombo, M. Civelli, and G. De Giacomi et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy J Am Coll Cardiol 55 2010 213 220
144. M.F. Stoddard, J. Seeger, N.E. Liddell, T.J. Hadley, D.M. Sullivan, and
145. I. Dorup, G. Levitt, I. Sullivan, and K. Sorensen Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function Heart 90 2004 1214 1216
146. B.W. Eidem, B.G. Sapp, C.R. Suarez, and F. Cetta Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children Am J Cardiol 87 2001 1120 1122 A9
147. M. Ishii, T. Tsutsumi, W. Himeno, G. Eto, J. Furui, and K. Hashino et al. Sequential evaluation of left ventricular myocardial performance in children after anthracycline therapy Am J Cardiol 86 2000 1279 1281 A9
148. L.E. Rohde, A. Baldi, C. Weber, G. Geib, N.G. Mazzotti, and M. Fiorentini et al. Tei index in adult patients submitted to adriamycin chemotherapy: failure to predict early systolic dysfunction. Diagnosis of adriamycin cardiotoxicity Int J Cardiovasc Imaging 23 2007 185 191
149. P. Pellicori, A. Calicchia, F. Lococo, G. Cimino, and C. Torromeo Subclinical anthracycline cardiotoxicity in patients with acute promyelocytic leukemia in long-term remission after the AIDA protocol Congest Heart Fail 18 2012 217 221
150. E. Ho, A. Brown, P. Barrett, R.B. Morgan, G. King, and M.J. Kennedy et al. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study Heart 96 2010 701 707
151. A.C. Nagy, E. Tolnay, T. Nagykalnai, and T. Forster Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI Neoplasma 53 2006 511 517
152. A.C. Nagy, Z. Cserep, E. Tolnay, T. Nagykalnai, and T. Forster Early diagnosis of chemotherapy-induced cardiomyopathy: a prospective tissue Doppler imaging study Pathol Oncol Res 14 2008 69 77
153. H. Sawaya, I.A. Sebag, J.C. Plana, J.L. Januzzi, B. Ky, and V. Cohen et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients Am J Cardiol 107 2011 1375 1380
154. J. Ganame, P. Claus, A. Uyttebroeck, M. Renard, J. D'hooge, and B. Bijnens et al. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients J Am Soc Echocardiogr 20 2007 1351 1358
155. K. Negishi, T. Negishi, J.L. Hare, B.A. Haluska, J.C. Plana, and T.H. Marwick Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity J Am Soc Echocardiogr 26 2013 493 498
156. N. Fallah-Rad, J.R. Walker, A. Wassef, M. Lytwyn, S. Bohonis, and T. Fang et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy J Am Coll Cardiol 57 2011 2263 2270
157. P. Thavendiranathan, F. Poulin, K.D. Lim, J.C. Plana, A. Woo, and T.H. Marwick Use of Myocardial Strain Imaging by Echocardiography for the Early Detection of Cardiotoxicity in Patients During and After Cancer Chemotherapy: A Systematic Review J Am Coll Cardiol 63 2014 2751 2768
158. R. Jurcut, H. Wildiers, J. Ganame, J. D'hooge, J. De Backer, and H. Denys et al. Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer J Am Soc Echocardiogr 21 2008 1283 1289
159. J.T. Poterucha, S. Kutty, R.K. Lindquist, L. Li, and B.W. Eidem Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction J Am Soc Echocardiogr 25 2012 733 740
160. H. Sawaya, I.A. Sebag, J.C. Plana, J.L. Januzzi, B. Ky, and T.C. Tan et al. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab Circ Cardiovasc Imaging 5 2012 596 603
161. P.W. Stoodley, D.A. Richards, R. Hui, A. Boyd, P.R. Harnett, and S.R. Meikle et al. Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy Eur J Echocardiogr 12 2011 945 952
162. J.L. Hare, J.K. Brown, R. Leano, C. Jenkins, N. Woodward, and T.H. Marwick Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab Am Heart J 158 2009 294 301
163. Y.F. Cheung, W.J. Hong, G.C. Chan, S.J. Wong, and S.Y. Ha Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy Heart 96 2010 1137 1141
164. H.R. Tsai, O. Gjesdal, T. Wethal, K.H. Haugaa, A. Fossa, and S.D. Fossa et al. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy Am J Cardiol 107 2011 472 477
165. G. Kocabay, D. Muraru, D. Peluso, U. Cucchini, S. Mihaila, and S. Padayattil-Jose et al. Normal left 1 ventricular mechanics by two-dimensional speckle tracking echocardiography. Reference values in healthy adults Rev Esp Cardiol 2014
166. K. Takigiku, M. Takeuchi, C. Izumi, S. Yuda, K. Sakata, and N. Ohte et al. Normal range of left ventricular 2-dimensional strain: Japanese Ultrasound Speckle Tracking of the Left Ventricle (JUSTICE) study Circ J 76 2012 2623 2632
167. T. Kuznetsova, L. Herbots, T. Richart, J. D'hooge, L. Thijs, and R.H. Fagard et al. Left ventricular strain and strain rate in a general population Eur Heart J 29 2008 2014 2023
168. S. Cheng, M.G. Larson, E.L. McCabe, E. Osypiuk, B.T. Lehman, and P. Stanchev et al. Reproducibility of Speckle-Tracking-Based Strain Measures of Left Ventricular Function in a Community-Based Study J Am Soc Echocardiogr 26 2013 1258 1266.e2
169. N. Risum, S. Ali, N.T. Olsen, C. Jons, M.G. Khouri, and T.K. Lauridsen et al. Variability of global left ventricular deformation analysis using vendor dependent and independent two-dimensional speckle-tracking software in adults J Am Soc Echocardiogr 25 2012 1195 1203
170. A Unique Collaboration to Advance Strain Imaging Journal of the American Society of Echocardiography 26 2013 A21 A22
171. D. Cardinale, and M.T. Sandri Role of biomarkers in chemotherapy-induced cardiotoxicity Prog Cardiovasc Dis 53 2010 121 129
172. T. Reichlin, W. Hochholzer, S. Bassetti, S. Steuer, C. Stelzig, and S. Hartwiger et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays N Engl J Med 361 2009 858 867
173. R.S. Wright, J.L. Anderson, C.D. Adams, C.R. Bridges, D.E. Casey Jr., and S.M. Ettinger et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons J Am Coll Cardiol 57 2011 e215 367
174. D. Cardinale, M.T. Sandri, A. Colombo, N. Colombo, M. Boeri, and G. Lamantia et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy Circulation 109 2004 2749 2754
175. H.W. Auner, C. Tinchon, W. Linkesch, A. Tiran, F. Quehenberger, and H. Link et al. Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies Ann Hematol 82 2003 218 222
176. G. Specchia, C. Buquicchio, N. Pansini, F. Di Serio, V. Liso, and D. Pastore et al. Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines J Lab Clin Med 145 2005 212 220
177. S. Kilickap, I. Barista, E. Akgul, K. Aytemir, S. Aksoyek, and S. Aksoy et al. cTnT can be a useful marker for early detection of anthracycline cardiotoxicity Ann Oncol 16 2005 798 804
178. D. Cardinale, A. Colombo, R. Torrisi, M.T. Sandri, M. Civelli, and M. Salvatici et al. Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation J Clin Oncol 28 2010 3910 3916
179. P.G. Morris, C. Chen, R. Steingart, M. Fleisher, N. Lin, and B. Moy et al. Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib Clin Cancer Res 17 2011 3490 3499
180. M. Schmidinger, C.C. Zielinski, U.M. Vogl, A. Bojic, M. Bojic, and C. Schukro et al. Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma J Clin Oncol 26 2008 5204 5212
181. S. Ederhy, C. Massard, G. Dufaitre, R. Balheda, C. Meuleman, and C.G. Rocca et al. Frequency and management of troponin I elevation in patients treated with molecular targeted therapies in phase I trials Invest New Drugs 30 2012 611 615
182. D.J. Lenihan, M.R. Massey, K.B. Baysinger, C.L. Adorno, C.L. Warneke, and D. Steinert et al. Superior Detection of Cardiotoxicity during Chemotherapy Using Biomarkers J Card Fail 13 2007 S151
183. S. Romano, S. Fratini, E. Ricevuto, V. Procaccini, G. Stifano, and M. Mancini et al. Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients Br J Cancer 105 2011 1663 1668
184. F. Dodos, T. Halbsguth, E. Erdmann, and U.C. Hoppe Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults Clin Res Cardiol 97 2008 318 326
185. K. Knobloch, J. Tepe, R. Lichtinghagen, H.J. Luck, and P.M. Vogt Monitoring of cardiotoxicity during immunotherapy with Herceptin using simultaneous continuous wave Doppler depending on N-terminal pro-brain natriuretic peptide Clin Med 7 2007 88 89 author reply 89
186. K. Knobloch, J. Tepe, D. Rossner, R. Lichtinghagen, H.J. Luck, and K.H. Busch et al. Combined NT-pro-BNP and CW-Doppler ultrasound cardiac output monitoring (USCOM) in epirubicin and liposomal doxorubicin therapy Int J Cardiol 128 2008 316 325
187. T. Nousiainen, E. Jantunen, E. Vanninen, J. Remes, O. Vuolteenaho, and J. Hartikainen Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma Eur J Haematol 62 1999 135 141
188. Fish M, Lenihan DJ. Effectiveness of using biomarkers to detect and identify cardiotoxicity and describe treatment (PREDICT). 2013;(Accessed 2014 Mar 11) http://clinicaltrials.gov/ct2/show/NCT01311843.
189. K. Kalam, and T.H. Marwick Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis Eur J Cancer 49 2013 2900 2909
190. S.E. Lipshultz, N. Rifai, V.M. Dalton, D.E. Levy, L.B. Silverman, and S.R. Lipsitz et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia N Engl J Med 351 2004 145 153
191. E.C. van Dalen, H.N. Caron, H.O. Dickinson, and L.C. Kremer Cardioprotective interventions for cancer patients receiving anthracyclines Cochrane Database Syst Rev 2011 CD003917
192. S. Seicean, A. Seicean, J.C. Plana, G.T. Budd, and T.H. Marwick Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study J Am Coll Cardiol 60 2012 2384 2390
193. Z. Acar, A. Kale, M. Turgut, S. Demircan, K. Durna, and S. Demir et al. Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy J Am Coll Cardiol 58 2011 988 989
194. J.H. Silber, A. Cnaan, B.J. Clark, S.M. Paridon, A.J. Chin, and J. Rychik et al. Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines J Clin Oncol 22 2004 820 828
195. A.H. Blaes, P. Gaillard, B.A. Peterson, D. Yee, and B. Virnig Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy Breast Cancer Res Treat 122 2010 585 590
196. S. Seicean, A. Seicean, N. Alan, J.C. Plana, G.T. Budd, and T.H. Marwick Cardioprotective Effect of Beta-Adrenoceptor Blockade in Breast Cancer Patients Undergoing Chemotherapy: A Follow-Up Study of Heart Failure Circ Heart Fail 6 2013 420 426
197. N. Kalay, E. Basar, I. Ozdogru, O. Er, Y. Cetinkaya, and A. Dogan et al. Protective effects of carvedilol against anthracycline-induced cardiomyopathy J Am Coll Cardiol 48 2006 2258 2262
198. H. Nakamae, K. Tsumura, Y. Terada, T. Nakane, M. Nakamae, and K. Ohta et al. Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone Cancer 104 2005 2492 2498
199. C. Cadeddu, A. Piras, G. Mantovani, M. Deidda, M. Dessi, and C. Madeddu et al. Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment Am Heart J 160 2010 487.e1 487.e7
200. T. Negishi, K. Negishi, D. Agler, J.C. Plana, B. Haluska, and T. Marwick Cardio-protective effect of beta-blockade during chemotherapy for breat cancer J Am Coll Cardiol 59 2012 E1248
201. D.G. Powe, and F. Entschladen Targeted therapies: Using beta-blockers to inhibit breast cancer progression Nat Rev Clin Oncol 8 2011 511 512
202. J.S. Gottdiener, D.J. Mathisen, J.S. Borer, R.O. Bonow, C.E. Myers, and L.H. Barr et al. Doxorubicin cardiotoxicity: assessment of late left ventricular dysfunction by radionuclide cineangiography Ann Intern Med 94 1981 430 435
203. B.W. Choi, H.J. Berger, P.E. Schwartz, J. Alexander, F.J. Wackers, and A. Gottschalk et al. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance Am Heart J 106 1983 638 643
204. S.T. Palmeri, R.O. Bonow, C.E. Myers, C. Seipp, J. Jenkins, and M.V. Green et al. Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionuclide angiography Am J Cardiol 58 1986 607 613
205. M.C. Pinder, Z. Duan, J.S. Goodwin, G.N. Hortobagyi, and S.H. Giordano Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer J Clin Oncol 25 2007 3808 3815
206. N.G. Bellenger, M.I. Burgess, S.G. Ray, A. Lahiri, A.J. Coats, and J.G. Cleland et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 21 2000 1387 1396
207. M.M. Naik, G.A. Diamond, T. Pai, A. Soffer, and R.J. Siegel Correspondence of left ventricular ejection fraction determinations from two-dimensional echocardiography, radionuclide angiography and contrast cineangiography J Am Coll Cardiol 25 1995 937 942
208. J. Mogelvang, K.H. Stokholm, K. Saunamaki, A. Reimer, M. Stubgaard, and C. Thomsen et al. Assessment of left ventricular volumes by magnetic resonance in comparison with radionuclide angiography, contrast angiography and echocardiography Eur Heart J 13 1992 1677 1683
209. R.S. Jiji, C.M. Kramer, and M. Salerno Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs J Nucl Cardiol 19 2012 377 388
210. N. van Royen, C.C. Jaffe, H.M. Krumholz, K.M. Johnson, P.J. Lynch, and D. Natale et al. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions Am J Cardiol 77 1996 843 850
211. S.A. Abbasi, A. Ertel, R.V. Shah, V. Dandekar, J. Chung, and G. Bhat et al. Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients J Cardiovasc Magn Reson 15 2013 89 429 X-15-89
212. J.P. Greenwood, N. Maredia, J.F. Younger, J.M. Brown, J. Nixon, and C.C. Everett et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial Lancet 379 2012 453 460
213. C. Klein, S.G. Nekolla, F.M. Bengel, M. Momose, A. Sammer, and F. Haas et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography Circulation 105 2002 162 167
214. T.G. Neilan, O.R. Coelho-Filho, D. Pena-Herrera, R.V. Shah, M. Jerosch-Herold, and S.A. Francis et al. Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines Am J Cardiol 110 2012 1679 1686
215. G. Smith, P. Kotwinski, J.P. Carpenter, M. Hugh, and D. Pennell Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity J Cardiovasc Magn Reson 11 2009 P18
216. D.J. Pennell, U.P. Sechtem, C.B. Higgins, W.J. Manning, G.M. Pohost, and F.E. Rademakers et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report J Cardiovasc Magn Reson 6 2004 727 765
217. N. Kawel, E.B. Turkbey, J.J. Carr, J. Eng, A.S. Gomes, and W.G. Hundley et al. Normal left ventricular myocardial thickness for middle-aged and older subjects with steady-state free precession cardiac magnetic resonance: the multi-ethnic study of atherosclerosis Circ Cardiovasc Imaging 5 2012 500 508
218. The clinical role of magnetic resonance in cardiovascular disease. Task Force of the European Society of Cardiology, in collaboration with the Association of European Paediatric Cardiologists Eur Heart J 19 1998 19 39
219. N.G. Bellenger, L.C. Davies, J.M. Francis, A.J. Coats, and D.J. Pennell Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance J Cardiovasc Magn Reson 2 2000 271 278
220. F. Grothues, G.C. Smith, J.C. Moon, N.G. Bellenger, P. Collins, and H.U. Klein et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy Am J Cardiol 90 2002 29 34
221. A.C. Armstrong, S. Gidding, O. Gjesdal, C. Wu, D.A. Bluemke, and J.A. Lima LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice JACC Cardiovasc Imaging 5 2012 837 848
222. J. Vogel-Claussen, J.P. Finn, A.S. Gomes, G.W. Hundley, M. Jerosch-Herold, and G. Pearson et al. Left ventricular papillary muscle mass: relationship to left ventricular mass and volumes by magnetic resonance imaging J Comput Assist Tomogr 30 2006 426 432
223. K. Alfakih, T. Bloomer, S. Bainbridge, G. Bainbridge, J. Ridgway, and G. Williams et al. A comparison of left ventricular mass between two-dimensional echocardiography, using fundamental and tissue harmonic imaging, and cardiac MRI in patients with hypertension Eur J Radiol 52 2004 103 109
224. C.G. Missouris, S.M. Forbat, D.R. Singer, N.D. Markandu, R. Underwood, and G.A. MacGregor Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension J Hypertens 14 1996 1005 1010
225. M. Goldman, R. Matthews, H. Meng, T. Bilfinger, and S. Kort Evaluation of cardiac involvement with mediastinal lymphoma: the role of innovative integrated cardiovascular imaging Echocardiography 29 2012 E189 E192
226. R.J. Kim, E. Wu, A. Rafael, E.L. Chen, M.A. Parker, and O. Simonetti et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
227. J. Perez-Rodriguez, S. Lai, B.D. Ehst, D.M. Fine, and D.A. Bluemke Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment-report of 33 cases Radiology 250 2009 371 377
228. L. Iles, H. Pfluger, A. Phrommintikul, J. Cherayath, P. Aksit, and S.N. Gupta et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping J Am Coll Cardiol 52 2008 1574 1580
229. M. Ugander, A.J. Oki, L.Y. Hsu, P. Kellman, A. Greiser, and A.H. Aletras et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology Eur Heart J 33 2012 1268 1278
230. E. Tham, K. Chow, M. Spavor, J.J. Pagano, M. Haykowsky, and R.J. Thompson Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy J Cardiovasc Magn Reson 13 2011 P276
231. T.G. Neilan, O.R. Coelho-Filho, R.V. Shah, J.H. Feng, D. Pena-Herrera, and D. Mandry et al. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy Am J Cardiol 111 2013 717 722
232. J. Korinek, J. Kjaergaard, P.P. Sengupta, S. Yoshifuku, E.M. McMahon, and S.S. Cha et al. High spatial resolution speckle tracking improves accuracy of 2-dimensional strain measurements: an update on a new method in functional echocardiography J Am Soc Echocardiogr 20 2007 165 170
233. B.C. Drafts, K.M. Twomley, R. D'Agostino Jr., J. Lawrence, N. Avis, and L.R. Ellis et al. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease JACC Cardiovasc Imaging 6 2013 877 885
234. C. Mornos, and L. Petrescu Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist Can J Physiol Pharmacol 91 2013 601 607
235. S. Baratta, M. Damiano, M. Marchese, J. Trucco, M. Rizzo, and F. Bernok et al. Serum Markers, Conventional Doppler Echocardiography and Two-dimensional Systolic Strain in the Diagnosis of Chemotherapy-Induced Myocardial Toxicity Rev Argent Cardiol 81 2013 151 158
236. A.M. Mavinkurve-Groothuis, K.A. Marcus, M. Pourier, J. Loonen, T. Feuth, and P.M. Hoogerbrugge et al. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study Eur Heart J Cardiovasc Imaging 14 2013 562 569
237. T. Stanton, R. Leano, and T.H. Marwick Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring Circ Cardiovasc Imaging 2 2009 356 364
238. G.Y. Cho, T.H. Marwick, H.S. Kim, M.K. Kim, K.S. Hong, and D.J. Oh Global 2-dimensional strain as a new prognosticator in patients with heart failure J Am Coll Cardiol 54 2009 618 624